Background: Hospital length of stay (LOS) is an important measure to determine resource utilization and efficiency of care for inpatients. No existing objective methodology is available to determine where and how pharmacy departments can have maximal impact on reducing extended LOS. Objective: An objective methodology to guide decisions by hospital pharmacy departments on reducing extended LOS is described. Methods: University of North Carolina Medical Center's LOS was compared to hospitals with similar inpatient bed size and case mix index. Objective methodology using pharmacy intensity weight, LOS index, and relative number of cases overall and by hospital service was developed to identify targets of impacting LOS for a pharmacy department. Results: The novel Pharmacy Opportunity Length of Stay (POLOS) formula was developed to prioritize each Medicare Severity Diagnosis Related Group (MSDRG) based on the overall impact pharmacy can have on reducing extended LOS at an individual institution. An additional novel formula, Service Specific POLOS (SSPOLOS), was created to strategically target hospital services, as opposed to MSDRGs, allowing for effective deployment of targeted pharmacy interventions to decrease extended LOS. Conclusion: POLOS and SSPOLOS are novel formulas to guide pharmacy departments in objectively prioritizing and targeting resources to reduce extended LOS. The novel formulas can be used to quantify LOS performance at the hospital and pharmacy specific levels, in addition to providing a hospital service approach to launch LOS initiatives at health care institutions. To our knowledge, this represents the first opportunity for hospital pharmacy departments to objectively target and reduce extended LOS.
Introduction
As health care transitions from a fee-for-service to a feefor-performance model, it is prudent that value be the focus for a sustainable future of health care delivery. Value in health care is broadly defined as the outcomes achieved per dollar spent. 1, 2 Overutilization of health care in the United States is apparent when compared to other developed countries, as we spend 2.4 times more per person on health care and have similar or worse outcomes. 3 With ever-decreasing reimbursement rates for hospital charges, hospitals must efficiently utilize resources that achieve optimal outcomes while decreasing costs to provide maximal value for patients.
Hospital length of stay (LOS) is an important measure to determine resource utilization and efficiency of care for inpatients. LOS is the difference of days between the admission and discharge for a given patient's hospital stay. LOS can be utilized to explain hospital expenditures as a strong correlation between LOS and hospital costs has been found. 4 For a given hospital stay, an expected LOS can be calculated through algorithms that assess multiple patient factors including diagnosis, procedure(s), and other clinical information. When a hospital stay exceeds the number of expected days, this is deemed extended LOS. When a hospital stay significantly exceeds the number of expected days, this is often considered an LOS outlier. The outlier determination in the literature is described inconsistently; however, it is often derived on a percentile cutoff basis. While the opportunity to reduce LOS outliers may be minimal-due to unavoidable circumstances-there exists significant opportunity for institutions to focus efforts on reducing extended LOS, and thus increasing value by reducing overall expenses.
Background
When analyzing LOS performance, there exist multiple variables-reported by various groups-that should be considered. The University HealthSystem Consortium (UHC) is a collaboration of academic health systems across the United States that participate in data reporting and benchmarking for quality improvement. UHC reports a hospital LOS index for participating hospitals. This is a value of observed LOS divided by the expected LOS, based on UHC predictive risk model algorithms. A value greater than 1 would indicate an extended LOS was observed than what was expected for the given hospital stay. In addition, the Centers for Medicare and Medicaid Services (CMS) publish an annual list containing each Medicare Severity Diagnosis Related Group (MSDRG) with their respective relative weight (RW), and mean LOS values. RWs are calculated based on average resource consumption for a given MSDRG compared to the average consumption for all MSDRGs. Furthermore, the Truven Health Analytics Action OI tool provides a pharmacy intensity weight (PIW) for each MSDRG. PIW, much like RW, provides a weighting system for relative resource utilization per MSDRG; however, PIW focuses on median pharmacy costs. Currently, no formulas exist that account for these variables and specifically address hospital and pharmacy LOS opportunities.
Operationalizing new clinical initiatives across a hospital or health system requires a targeted approach to maximize resource efficiency. Therefore, before launching an LOS initiative, it will be pertinent to quantify LOS performance across an institution and prioritize targeted areas that will show maximal impact on LOS metrics. The purpose of this research is to demonstrate a novel approach to analyze and target extended LOS at the hospital and pharmacy specific levels.
The University of North Carolina (UNC) Medical Center is an 824-bed academic medical center. UNC Medical Center has a high volume of extended LOS for hospitalized inpatients than that of comparable hospitals within UHC, based on historical data and reports. The resultant effects of extended LOS contribute to the already problematic bed capacity issues, increased health care costs, and reduced margins on inpatient reimbursement. Therefore, reducing extended LOS has become a high priority initiative at UNC Medical Center.
A 2-phase retrospective analysis was performed to (1) identify and compare LOS performance at UNC Medical Center to that of similar institutions and (2) develop formulas to target and prioritize extended LOS at UNC Medical Center. Next, methodology was proposed to operationalize LOS action plans for future studies.
Methods (Phase I)

Data Sources
Through the UHC Clinical Data Base and Resource Manager (CDB/RM), members can query the database utilizing the report builder. Additionally, the CDB/RM contains a Hospital Profiler, which allows filtering and selection of comparison hospitals. To allow for comparison of UNC Medical Center to other large academic medical centers across the nation, it was practical to use the UHC CDB/ RM-Hospital Profiler to identify these hospitals, and compare using high-level hospital information. The filter settings were set to include ≥ 500 beds, AAMC (American Association of Medical Colleges) teaching hospitals, and reporting 4 quarters between 2014 Q1 and Q4. To continue classifying the selected hospitals, clinical outcome data were collected through the UHC CDB/RM using the same hospital set and time period from the Hospital Profiler. The selected exclusions included bad data, nonviable neonates, and LOS outliers. Bad data include, but are not limited to, null or blank values for hospital encounter or MSDRG, or if the MSDRG number is set to 999. LOS outliers are defined by UHC as any case with an inpatient LOS greater than the 99th percentile LOS by base MSDRG. UHC performs significance testing on LOS and demonstrates a statistically significant difference found between the observed and expected values at either the .05 level of significance ("*") or at the .01 levels ("**"). 5 No significance tests are performed for cases <10 for LOS.
Through institutional review board approval, patientlevel data were obtained for UNC Medical Center through querying of the local data warehouse. The report query was set to patient class: inpatient; admission discharge transfer (ADT) patient status: discharge; discharge date: January 1, 2014, to December 31, 2014; and included only UNC Medical Center. As previously mentioned, MSDRG RW and mean LOS values were obtained from CMS and PIW values were obtained from Truven Health Analytics Action OI.
Exclusions
Due to changes in MSDRG definitions by CMS in August 2014, the following MSDRGs were excluded from this analysis as they were not present for the entire study period: MSDRGs 484, 490, 491, 518, 519, and 520. Within the UHC risk model, the following MSDRGs were regrouped and reassigned to more clinically meaningful MSDRGs, and thus were excluded from this analysis: MSDRGs 003, 004, 998, and 999. Last, MSDRG 795 was excluded as a respective PIW value was not provided in the data set.
Results (Phase I)
Comparison of LOS Performance
Within the UHC CDB/RM, there are 135 AAMC teaching hospitals in the United States. A total of 80 hospitals met the inclusion criteria for the analysis. The majority of included hospitals are located in the Eastern half of the United States, with the highest frequency in the Mid-Atlantic region. The average acute care bed count was 796 (range: 501-2262), and the average case mix index (CMI) was 2.02 (range: 1.63-2.52; see Table 1 ). Utilizing the adjusted length of stay (ALOS) to account for differences in CMI (ALOS = [inpatient days]/[inpatient discharges * CMI]), UNC Medical Center had the 9th highest value (3.28), which is in the 90th percentile rank for included hospitals across the nation. 6 The ALOS for UNC Medical Center was in the 90th percentile rank for included hospitals across the nation. Additionally, Medicare CMI for UNC Medical Center was 2.01, which is in the 47th percentile rank for included hospitals ( Figure 1) .
A subset of 4 comparison hospitals was chosen based on similarities in both acute care beds and Medicare CMI. The hospital subset sample was selected by analyzing hospitals that fell within ±1 standard deviation of UNC Medical Center's acute care beds (824 ± 276; 548 − 1100) and ±1 standard deviation of UNC Medical Center's CMI (2.01 ± 0.21; 1.8 − 2.22). Within the comparison hospital subset, the ALOS ranged from 2.28 to 3.28, with UNC Medical Center having the highest value. These differences, when compared at the national or subset level, demonstrates significant opportunity to reduce extended LOS at UNC Medical Center, which can be quantified by an excess of 13, 105 inpatient days for 2014 ( Figure 2 ).
Methods (Phase II)
Development of LOS Opportunity Formulas
Analyzing the collected data at UNC Medical Center at the MSDRG level, it was apparent that a sole value could not single-handedly be used to describe LOS performance. For instance, MSDRG 665 PROSTATECTOMY W MCC had a high LOS-index value of 4.47; however, there was only a single case during the study period (after excluding outliers). With only a single case, focusing efforts on this MSDRG would likely not have a large impact or opportunity to reduce overall resource utilization and extended LOS. Therefore, the relative number of cases for each MSDRG needs to be taken into account. Next, it was logical to consider the differences in resource utilization between the MSDRGs. This can be quantified through the MSDRG RW for overall resource utilization, or the PIW for drug resource utilization. For example, appreciate the resource utilization differences between MSDRG 014 ALLOGENIC BONE MARROW TRANSPLANT (RW 10.99, PIW 77.27) to that of MSDRG 305 HYPERTENSION W/O MCC (RW 0.63, PIW 0.49). Therefore, the RW and PIW for each MSDRG need to be taken into account.
It was theorized that a novel formula combining the LOS index, number of cases, and RW or PIW for each MSDRG could provide a unique approach to quantify and target LOS performance. To provide a similar weight for each variable, it was necessary to normalize the number of cases and LOS index variance. For overall hospital resource utilization, the Length of Stay Opportunity (LOSO) formula was developed. The resultant number will allow for percentile ranking of each included MSDRG. Sorting the included MSDRG list for LOSO by percentile rank will give an order for which MSDRGs will have the greatest opportunity for reduction. Since LOS is affected by myriad of variables across multiple disciplines, as outlined in UHC Risk Modeling Summaries, it is prudent to determine how to adjust the LOSO formula to demonstrate where pharmacy can have the greatest impact on reducing extended LOS. Substituting the MSDRG RW value with the PIW will demonstrate more specifically the pharmacy resources and ultimately the impact pharmacy can play in reducing extended LOS. Thus, the Pharmacy Opportunity Length of Stay (POLOS) formula was developed.
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After applying the POLOS formula to the included MSDRGs, a percentile rank can be performed to demonstrate an order to which the highest value will represent the MSDRG with the maximal impact pharmacy can have on impacting the overall extended LOS for the institution.
With the MSDRGs selected, the next step was to determine which variables leading to an extended LOS that pharmacy can be focused on to deploy targeted pharmacy interventions.
For each MSDRG, the formulas are only applied to those with a LOS index greater than 1. In addition, a statistically significant difference must have been found between the observed and expected LOS (notated by * or **) to be included. This was to ensure that only the MSDRGs with extended LOS are included and thus have some degree of opportunity for optimization.
At UNC Medical Center, patient care is approached from a hospital service perspective (ie, medicine cardiology, surgical urology, etc), as opposed to a location-based approach. Each patient is assigned 1 of 63 hospital services on admission. For a given MSDRG, the distribution across the hospital may extend to multiple hospital services across UNC Medical Center. To accommodate for this approach, the Service Specific Pharmacy Opportunity Length of Stay (SSPOLOS) formula was developed that will allow targeting extended LOS at the hospital service level. This was achieved by summating the adjusted POLOS formula for all included MSDRGs for each service. To adjust the POLOS formula per hospital service, the raw POLOS score for each MSDRG is divided by the total number of MSDRG-specific cases seen across the hospital, and then multiplied by the number of MSDRGspecific cases seen on that particular service. This will result in a single SSPOLOS value assigned to each hospital service and will allow sorting to determine priority based on the highest values, which will subsequently be the targeted hospital service(s). 
Results (Phase II)
Application of LOS Formulas at UNC Medical Center
Utilizing the LOSO formula, the top 20 priority MSDRGs are identified. These priorities, based on rank, represent the MSDRGs with the highest opportunity to maximally reduce extended LOS. The #1 rank MSDRG with LOS opportunity for overall resource utilization impact was MSDRG 885 PSYCHOSES. While the MSDRG RW is low (1.02), the large number of cases (1594) and the moderate LOS index (1.30) are high drivers. This is followed by MSDRG 329 MAJOR SMALL & LARGE BOWEL PROCEDURES W MCC. This has a higher MSDRG RW (5.08) and high LOS index (1.47); however, it has a moderate number of cases (186; see Table 2 ). Utilizing the POLOS formula, the top 20 priority MSDRGS are identified. These priorities represent the MSDRGs with the highest opportunity for pharmacy to reduce extended LOS. The #1 rank MSDRG with LOS opportunity for pharmacy is MSDRG 837 CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC. This was driven by a high PIW (23.00), high LOS index (1.50), and a moderate number of cases (99). The second priority MSDRG 329 matches the LOSO priority. To note, MSDRG 885 PSYCHOSES has fallen to rank #6-compared to rank #1 with LOSO-since the PIW value for this MSDRG is relatively very low; however, it is still a high priority given the large number of cases (Table 3) .
When analyzing these top priority MSDRGs across the hospital, they are distributed among multiple hospital services. For example, the #1 rank POLOS MSDRG 837 appears on 5 different hospital services (Figure 3) .
Taking this into account, the SSPOLOS formula is utilized to target hospital services-rather than MSDRGsbased on the distribution of identified POLOS MSDRGs. The top 20 SSPOLOS are identified for UNC Medical Center. The #1 rank hospital service is medicine oncology/ hematology, followed by the rank #2 hospital service medicine hospitalist service (Table 4) .
Discussion
With these methods, notable limitations exist that should be acknowledged when assessing LOS. The enhanced value equation for health care includes quality and service over the cost of health care. 1 With initiatives to reduce costs, there must be a balance to ensure the level of service and quality are not compromised, as such to avoid diminished value. With initiatives to reduce LOS, it will be pertinent to also measure and track outcomes data, including readmission rates.
MSDRGs are not assigned for an inpatient stay until after discharge, which may complicate targeting MSDRGs for LOS reduction. For each inpatient stay, a single MSDRG is assigned using the principle diagnosis, additional diagnoses, the principle procedure, additional procedures, sex, and discharge status. The assignments are determined based on ICD-9 or ICD-10 codes, which requires complete and accurate coding documentation by health information management (HIM) personnel. 7 Therefore, prospective MSDRG assignment in the acute care setting cannot be-accurately-performed. Since this analysis focused on identifying LOS performance for given MSDRGs, it was pertinent to develop alternative strategies to more efficiently target intended patient populations. The SSPOLOS formula was developed to target hospital services, as opposed to MSDRGs, as an alternative approach. There are limitations with the formula, in that it does not account for potential differences in LOS performance for a given MSDRG across each of the hospital services, instead it calculates equal weight based on the number of cases seen. Once targeted MSDRGs or hospital services are determined, a multifactorial approach must be initiated to diagnose and create effective changes for a sustainable reduction in extended LOS. From a pharmacy perspective, it is pertinent to assess if targeted area(s) require enhanced pharmacy services (ie, transitions of care, bed side delivery of medications, etc). Studying the admission and discharge trends can reveal great insights into workflow inefficiencies and bottlenecks. A target LOS value should be communicated with the affected clinical teams, to assist in influencing discharging behaviors solely by being aware of what is considered an extended LOS for their patients or hospital service. Last, through utilization of the UHC Risk Model for LOS, a prescriptive analytics tool can be built into the electronic health record environment, which ties targeted clinical interventions to known factors that lead to extended LOS, which is MSDRG specific.
Limitations
There are advantages and limitations for utilizing the methodology described in this research to quantify LOS performance and prioritize targeted areas for extended LOS reduction. Previous methods used to identify poor LOS performance areas were to utilize only the highest LOS Index values for a given institution. While this value is important to describe LOS performance, it does not account for the number of cases or the overall resource impact. Using the POLOS and SSPOLOS formulas will provide a single value for deeper insight into the meaningful extended LOS cases through targeting MSDRGs and hospital services, respectively, of which the LOS Index value alone cannot provide. Despite the distinct advantages of these formulas, there are limitations that should be considered. The LOS Index and significance testing were provided through the UHC CDB/ RM. For non-UHC hospitals, these values may not be readily available and may require manual calculation. Although the formulas and results of this study provide logical face validity through equal weighting of included variables, a more robust formula validation will further strengthen its use, which is planned for future studies.
Conclusion
POLOS and SSPOLOS are novel formulas that pharmacy departments can use to objectively prioritize and target resources to reduce extended LOS in acute care settings. The novel formulas can be used to quantify LOS performance at the hospital and pharmacy specific levels, in addition to providing a hospital service approach to launch LOS initiatives at health care institutions. To our knowledge, these formulas are the first to be developed and published for hospital pharmacy departments to objectively target and reduce extended LOS.
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